Team

Meet the passionate minds driving our vision forward.

Core Team Values

These values are the foundation of our teamwork, trust, and integrity—driving
every decision we make and shaping the way we collaborate,
innovate, and grow together.

united by values.

Management & Directors

President & CEO

Serial Entrepreneur - Early Stage Technology

john Lawson

Founder, board chairman & Shief Scientist

LAWRENCE TOLL PH.D.

Founder, Chief Neuropharmacologist & Board Member

TIMMY CHOU

Vice President, CFO & Board Member

CHRIS TEW

Vice President and Board Member

Scientific Advisors

Daniel E. Levy,
Ph.D.

Consultant, Chemical Synthesis and Manufacturing Scale-up

Timothy P. Bradshaw,
Ph.D.

Consultant, Preclinical and Clinical Trial Planning

David Heal PhD, DSc, FRSC, HonFBPhS

Consultant, NHP Studies

Mei-Chuan (Holden)
Ko, Ph.D.

Consultant, NHP Studies

James R Myer.
BS, DABT

Consultant, Toxicology

Chantal Deziel,
B.Sc, MBA

Consultant, QA/QC

About Us

Phoenix PharmaLabs welcomes inquiries by organizations seeking a beneficial relationship. Please contact us to explore potential opportunities.

Mr. Crossman is responsible for the overall management of the Company and the creation, planning and execution of business and financial strategies and corporate development activities, including capital generation.
Crossman is a senior management professional with international and domestic experience as CEO, COO and CFO of enterprises ranging from entrepreneurial start-ups to Fortune 500 level companies. He has a proven track record of successfully commercializing various emerging technologies including manufacturing and industrial systems, computer software, marine bioremediation, nanotechnology and life sciences.

Mr.Crossman has assisted numerous early-stage companies to refine business strategies, commercialize new products, raise capital, license technologies, scale revenues and production, and expand into global markets. As CEO of ISOPur Fluid Technologies, Crossman led the company from product introduction to global growth with expanding applications in multiple vertical markets. Important strategic alliances were developed with Siemens, BHP, Atlas Copco, Hess, Sanwa Shoko and others, creating a platform for continued strong growth.

The value of the founding shareholders’ common stock increased more than tenfold in less than three years under Crossman’s leadership. As CFO of Otis Elevator Company – Asia Pacific Operations, Crossman evaluated, negotiated and developed acquisitions, joint ventures and major capital investments in China, Japan, Korea, India, Southeast Asia, and Australia. Mr. Crossman contributed to profit growth of 20% per year and market share gains of 1% per year in this mature multi-billion dollar operation spanning 23 countries, despite aggressive competition from large Asian conglomerates. The joint ventures that he helped developed in China are among the most profitable operations of United Technologies Corp today. Bill holds a BS degree from the U.S. Merchant Marine Academy at Kings Point and a MBA from the Haas School of Business at the University of California – Berkeley.